Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

iPSC-Derived Cell Therapies Summit

Evvnt Promotion / evvnt
-
07.12.2021 - 09.12.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temi della conferenza
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies

The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/853667-3?pid=4832

Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/853667-1?pid=4832
Mr. Customer Services
 
Categorie
Medicina General, Ricerca clinica
Lingua
Inglese
Quote del Congresso
USD 1899.00 - USD 3597.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Anästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthnewTreeAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Public Health Association (EUPHA)Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Akademie der Ärzte